Real-World Treatment Patterns in Patients with Atopic Dermatitis Initiating Ruxolitinib Cream: A 12-Month Follow-Up Analysis of a US Payer Claims Database.

Clinicoecon Outcomes Res · 2026 · PMC13084351 · PMID 42004157

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Post-index treatment patterns showed a decreasing trend in corticosteroid use, with topical corticosteroid use dropping from 31.3% in months 1–6 to 26.6% in months 7–12, and systemic corticosteroid use stabilizing after an initial decrease (16.0% to 16.6%).

also in 25,480 other papers

an encouraging trendno p-value reported

39–41 Prednisone utilization and equivalent dosage decreased substantially in the 1–6-month follow-up and even more deeply in the 7–12-month follow-up, which is an encouraging trend.

also in 160 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.